Injectable in situ forming hybrid iron oxide-hyaluronic acid hydrogel for magnetic resonance imaging and drug delivery

Macromol Biosci. 2014 Sep;14(9):1249-59. doi: 10.1002/mabi.201400117. Epub 2014 May 23.

Abstract

The development of multimodal in situ cross-linkable hyaluronic acid nanogels hybridized with iron oxide nanoparticles is reported. Utilizing a chemoselective hydrazone coupling reaction, the nanogels are converted to a macroscopic hybrid hydrogel without any additional reagent. Hydrophobic cargos remain encapsulated in the hydrophobic domains of the hybrid hydrogel without leakage. However, hydrogel degradation with hyaluronidase liberates iron oxide nanoparticles. This allows the utilization of imaging agents as tracers of the hydrogel degradation. UV-vis spectrometry and MRI studies reveal that the degradability of the hydrogels correlates with their structure. The hydrogels presented here are very promising theranostic tools for hyaluronidase-mediated delivery of hydrophobic drugs, as well as imaging of hydrogel degradation and tracking of degradation products in vivo.

Keywords: hyaluronan hydrogels; hybrid organic-inorganic nanogels; in situ cross-linking; iron oxide nanoparticles; magnetic resonance imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media* / chemistry
  • Contrast Media* / pharmacology
  • Drug Delivery Systems / methods*
  • Ferric Compounds* / chemistry
  • Ferric Compounds* / pharmacology
  • Hyaluronic Acid* / chemistry
  • Hyaluronic Acid* / pharmacology
  • Hydrogels* / chemistry
  • Hydrogels* / pharmacology
  • Magnetic Resonance Imaging*
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure

Substances

  • Contrast Media
  • Ferric Compounds
  • Hydrogels
  • ferric oxide
  • Hyaluronic Acid